A
Consortex Karl Doelitzch
APOWERTOOL NSE
Consortex Karl Doelitzch
IndustrialsNSE: APOWERTOOL Industrial Manufacturing
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
1- Company has low interest coverage ratio.
Quarterly Results
| Particulars | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3 | 3 | 4 | 3 | 2 | 2 | 1 | 3 | 2 | 1 | 2 | 1 | 3 |
| Expenses | 55 | 34 | 32 | 27 | 49 | 33 | 32 | 55 | 41 | 45 | 53 | 81 | 106 |
| Operating Profit | -52 | -32 | -28 | -24 | -46 | -30 | -31 | -52 | -39 | -44 | -51 | -80 | -103 |
| OPM % | -1719% | -1208% | -737% | -768% | -1885% | -1267% | -3024% | -2032% | -2435% | -2981% | -2714% | -8671% | -3678% |
| Other Income | 2 | 6 | 6 | 13 | 6 | 4 | 4 | 4 | 2 | 1 | 1 | 4 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| PBT | -51 | -28 | -24 | -13 | -42 | -28 | -28 | -50 | -39 | -44 | -52 | -77 | -102 |
| Tax % | 0% | 0% | 0% | 0% | 0% | -4% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -51 | -28 | -24 | -13 | -42 | -27 | -28 | -50 | -39 | -44 | -52 | -77 | -102 |
| EPS in Rs | -2.34 | -1.27 | -1.1 | -0.58 | -1.91 | -1.22 | -1.29 | -2.28 | -1.79 | -2.01 | -2.36 | -3.4 | -4.48 |
Profit & Loss
| Particulars | Mar 2006 |
|---|---|
| Sales | 0 |
| Expenses | 0 |
| Operating Profit | 0 |
| Other Income | -10 |
| Interest | 4 |
| Depreciation | 1 |
| PBT | -14 |
| Tax % | 0% |
| Net Profit | -14 |
| Div. Payout % | 0% |
Balance Sheet
| Particulars | Mar 2006 |
|---|---|
| Equity Capital | 26 |
| Reserves | -54 |
| Borrowings | 53 |
| Other Liabilities | 0 |
| Total Liabilities | 25 |
| Fixed Assets | 24 |
| CWIP | 0 |
| Investments | 0 |
| Other Assets | 1 |
| Total Assets | 25 |
Cash Flow
| Particulars | Mar 2006 |
|---|---|
| Operating | -3 |
| Investing | 8 |
| Financing | -5 |
| Net Cash Flow | 0 |
| Free Cash Flow | 5 |
| CFO/OP | 7,500 |
Ratios
| Particulars | Mar 2008 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 111 | 28 | 39 | 31 | 36 | 3 | 66 | 48 | 40 | 22 | 40 | 73 |
| Inventory Days | 200 | 165 | 183 | 222 | 329 | 0 | — | — | — | — | — | — |
| Days Payable | 157 | 89 | 78 | 91 | 134 | — | — | — | — | — | — | — |
| Cash Conversion Cycle | 154 | 105 | 144 | 162 | 231 | 3 | 66 | 48 | 40 | 22 | 40 | 73 |
| Working Capital Days | 139 | 49 | 55 | 42 | 82 | 23 | 704 | 1,084 | 234 | 265 | 101 | -440 |
| ROCE % | 8% | — | 13% | 15% | 24% | -4% | -54% | -58% | -118% | -53% | -36% | -87% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Consortex Karl Doelitzch insights
34 extracted metrics + investor summaries across FY06–FY25.
Documents
1
Announcement under Regulation 30 (LODR)-Allotment
15h - Allotted 31,768,764 shares to promoter at Rs.134 each; proceeds Rs.425.70 crore. 15h - Allotted 31,768,764 shares to promoter at Rs.134 each; proceeds Rs.425.70 crore.
2
Board Meeting Outcome for ALLOTMENT OF 3,17,68,764 EQUITY SHARES OF THE COMPANY ON PREFERENTIAL BASIS
15h - 3,17,68,764 shares allotted to Jasti Property at Rs134 on March 6, 2026; proceeds Rs4,257,014,376. 15h - 3,17,68,764 shares allotted to Jasti Property at Rs134 on March 6, 2026; proceeds Rs4,257,014,376.
3
Announcement under Regulation 30 (LODR)-Newspaper Publication
19 Feb - Window for Re-lodgment of transfer requests of physical securities 19 Feb - Window for Re-lodgment of transfer requests of physical securities
4
Clarification On Price Movement
6 Feb - Suven clarifies on Feb 6, 2026: no material Reg 30 event; price moves due to market speculation. 6 Feb - Suven clarifies on Feb 6, 2026: no material Reg 30 event; price moves due to market speculation.
5
Clarification sought from Suven Life Sciences Ltd
5 Feb - Exchange has sought clarification from Suven Life Sciences Ltd on February 5, 2026 with reference to significant movement in price, in order to ensure that … 5 Feb - Exchange has sought clarification from Suven Life Sciences Ltd on February 5, 2026 with reference to significant movement in price, in order to ensure that …
Frequently Asked Questions about Consortex Karl Doelitzch
Where is Consortex Karl Doelitzch (India) Ltd (APOWERTOOL) listed?
Consortex Karl Doelitzch (India) Ltd trades as APOWERTOOL on the NSE.
Which sector does Consortex Karl Doelitzch (India) Ltd belong to?
Consortex Karl Doelitzch (India) Ltd is classified under the Industrials sector, in the Industrial Manufacturing industry.
Company Information
Website consortexindia.com
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/APOWERTOOL.md for Consortex Karl Doelitzch (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.